Paper39199604
Antispasmodic Agents in Magnetic Resonance Imaging of the Urinary Bladder-A Narrative Review.
Sklinda K and 3 others. Cancers (Basel), 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Antispasmodic Agents in Magnetic Resonance Imaging of the Urinary Bladder-A Narrative Review. Papers, record 39199604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antispasmodic Agents in Magnetic Resonance Imaging of the Urinary Bladder-A Narrative Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28687912 | Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. | Eur Radiol | 2018 | https://conductscience.org/library/papers/28687912 | PubMed |
| 2 | 22270141 | Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration. | Eur Radiol | 2012 | https://conductscience.org/library/papers/22270141 | PubMed |
| 3 | 32516554 | Staging of bladder cancer with multiparametric MRI. | Br J Radiol | 2020 | https://conductscience.org/library/papers/32516554 | PubMed |
| 4 | 32286874 | Overview of VI-RADS in Bladder Cancer. | AJR Am J Roentgenol | 2020 | https://conductscience.org/library/papers/32286874 | PubMed |
| 5 | 901701 | Some effects of injected hyoscine butylbromide: a versatile class experiment in human pharmacology. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/901701 | PubMed |
| 6 | 29350179 | Risks in the clinical applications of scopolamine butylbromide injections. | Int J Clin Pharmacol Ther | 2018 | https://conductscience.org/library/papers/29350179 | PubMed |
| 7 | 11856085 | Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy--a comparative study with butyl scopolamine bromide. | Aliment Pharmacol Ther | 2002 | https://conductscience.org/library/papers/11856085 | PubMed |
| 8 | 28803622 | Effect of hyoscine butylbromide on prostate multiparametric MRI anatomical and functional image quality. | Clin Radiol | 2018 | https://conductscience.org/library/papers/28803622 | PubMed |
| 9 | 8661572 | Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. | Abdom Imaging | 1996 | https://conductscience.org/library/papers/8661572 | PubMed |
| 10 | 29755006 | Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). | Eur Urol | 2018 | https://conductscience.org/library/papers/29755006 | PubMed |
| 11 | 16817918 | Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. | Aliment Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16817918 | PubMed |
| 12 | 35972266 | Hyoscine butylbromide mode of action on bowel motility: From pharmacology to clinical practice. | Neurogastroenterol Motil | 2023 | https://conductscience.org/library/papers/35972266 | PubMed |
| 13 | 35729250 | Antiperistaltic effect and safety of L-menthol for esophagogastroduodenoscopy in the elderly with contraindication to hyoscine-N-butylbromide. | Sci Rep | 2022 | https://conductscience.org/library/papers/35729250 | PubMed |
| 14 | 17920868 | The value of hyoscine butylbromide in pelvic MRI. | Clin Radiol | 2007 | https://conductscience.org/library/papers/17920868 | PubMed |
| 15 | 32948089 | The Role of Imaging in Bladder Cancer Diagnosis and Staging. | Diagnostics (Basel) | 2020 | https://conductscience.org/library/papers/32948089 | PubMed |
| 16 | 17623875 | Artifacts and pitfalls in MR imaging of the pelvis. | J Magn Reson Imaging | 2007 | https://conductscience.org/library/papers/17623875 | PubMed |
| 17 | 33211143 | Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach. | Eur Radiol | 2021 | https://conductscience.org/library/papers/33211143 | PubMed |
| 18 | 37171269 | Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon. | Radiol Imaging Cancer | 2023 | https://conductscience.org/library/papers/37171269 | PubMed |
| 19 | 36597982 | The effect of anti-spasmodic administration on the accuracy of magnetic resonance imaging staging of rectal cancer. | ANZ J Surg | 2023 | https://conductscience.org/library/papers/36597982 | PubMed |
| 20 | 38584289 | MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy. | Cancer Imaging | 2024 | https://conductscience.org/library/papers/38584289 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39199604
GET https://conductscience.org/api/papers/v1/39199604/references?page=2